Professor Eisuke Fukuma, who has performed over 600 ProSense breast cancer cryoablation procedures, led a cryoablation symposium with ProSenseIceCure joined its exclusive regional distributor,.
The global microcatheters market is projected to reach USD 1,142 million by 2028 from USD 874 million in 2023, growing at a CAGR of 5.5% during the forecast period.
/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.
IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.